Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL

Zohreh Aminzadeh 1 , 2 , * , Davood Yadegarynia 1 , Alireza Fatemi 1 , Saieed Azad Armaki 1 and Bahram Aslanbeygi 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Center for Clinical Research, University of Queensland, Brisbane, Australia
Article information
  • Jundishapur Journal of Microbiology: September 01, 2013, 6 (7); e6699
  • Published Online: September 1, 2013
  • Article Type: Research Article
  • Received: June 8, 2012
  • Revised: July 24, 2012
  • Accepted: August 8, 2012
  • DOI: 10.5812/jjm.6699

To Cite: Aminzadeh Z, Yadegarynia D, Fatemi A, Azad Armaki S, Aslanbeygi B. Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric Gram-Negative Bacteria and Activity of Nitrofurantoin in the era of ESBL, Jundishapur J Microbiol. 2013 ; 6(7):e6699. doi: 10.5812/jjm.6699.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Alipourfard I, Nili NY. Antibiogram of Extended Spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from Hospital Samples. Bangladesh J Med Microbiol. 2010; 4(1): 32-36
  • 2. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med. 2002; 28(12): 1718-23[DOI][PubMed]
  • 3. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis. 1999; 29(6): 1419-22[DOI][PubMed]
  • 4. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006; 42 Suppl 4-72[DOI][PubMed]
  • 5. Aminizadeh Z, Kashi MS. Prevalence of multi-drug resistance and pandrug resistance among multiple gram-negative species: experience in one teaching hospital, Tehran, Iran. Int Res J Microbiol. 2011; 2: 90-95
  • 6. Srinivasan A, Wolfenden LL, Song X, Mackie K, Hartsell TL, Jones HD, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med. 2003; 348(3): 221-7[DOI][PubMed]
  • 7. Kiska DL, Gilligan PH. Manual of clinical microbiology. 2003; 8(1): 719-28
  • 8. Troillet N, Samore MH, Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis. 1997; 25(5): 1094-8[PubMed]
  • 9. Krcmery V, Jr, Trupl J, Kunova A, Spanik S, Ilavska I, Hel'pianska L, et al. Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratisl Lek Listy. 1996; 97(11): 647-51[PubMed]
  • 10. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis. 2002; 34(3): 340-5[DOI][PubMed]
  • 11. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003; 24(4): 284-95[DOI][PubMed]
  • 12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 13. Clinical and Laboratory Standard Methods. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. 2007;
  • 14. Geng SN, Zhou XH, Rui YY, Wang Q, Zhang J. [Distribution and drug resistance spectrum analysis of 2478 clinical bacterial and Candida isolates]. Nan Fang Yi Ke Da Xue Xue Bao. 2007; 27(4): 524-7[PubMed]
  • 15. Akyar I. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Mikrobiyol Bul. 2008; 42(4): 713-5[PubMed]
  • 16. Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008; 2(5): 354-8[PubMed]
  • 17. Grandesso S, Sapino B, Mazzucato S, Alessandrini R, Solinas M, Gion M. [Study on in-vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens]. Infez Med. 2010; 18(3): 162-8[PubMed]
  • 18. Rafay AM, Al-Muharrmi Z, Toki R. Prevalence of extended-spectrum beta-lactamases-producing isolates over a 1-year period at a University Hospital in Oman. Saudi Med J. 2007; 28(1): 22-7[PubMed]
  • 19. Idowu OJ, Onipede AO, Orimolade AE, Akinyoola LA, Babalola GO. Extended-spectrum Beta-lactamase Orthopedic Wound Infections in Nigeria. J Glob Infect Dis. 2011; 3(3): 211-5[DOI][PubMed]
  • 20. Asha Pai KB, Rai Rekha, Sanjeev H, Karnaker Vimal Kumar, Prasad Krishna. Nitrofurantoin: An Alternative Therapy for Uncomplicated Cystitis in the Era of Antimicrobial Resistance. J Clin Diagn Res. 2011; 5: 964-6
  • 21. TEKİN Alicem, DAL Tuba, DEVECİ Özcan, TEKİN Recep, BOZDAĞ Hasan, ÖZEKİNCİ Tuncer. In Vitro Efficacy of Nitrofurantoin and Some Antibiotics in Escherichia coli Strains Isolated from Urine Cultures. New J Med. 2012; 29(2): 88-91
  • 22. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis. 2003; 36(2): 183-7[DOI][PubMed]
  • 23. Hamze M, Dabboussi F, Izard D. [Enterobacterial susceptibility to antibiotics in northern Lebanon (1998-2001)]. Sante. 2003; 13(2): 107-12[PubMed]
  • 24. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22(3): 172-4[PubMed]
  • 25. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect. 2008; 14 Suppl 1: 198-202[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments